Shop Apotheke Europe N.V.
Shop Apotheke Europe N.V. Fundamental Analysis
Shop Apotheke Europe N.V. (SAEYY) shows moderate financial fundamentals with a PE ratio of -31.58, profit margin of -1.28%, and ROE of -7.70%. The company generates $2.9B in annual revenue with strong year-over-year growth of 31.79%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 29.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SAEYY's fundamental strength across five key dimensions:
Efficiency Score
WeakSAEYY struggles to generate sufficient returns from assets.
Valuation Score
ExcellentSAEYY trades at attractive valuation levels.
Growth Score
ModerateSAEYY shows steady but slowing expansion.
Financial Health Score
ExcellentSAEYY maintains a strong and stable balance sheet.
Profitability Score
WeakSAEYY struggles to sustain strong margins.
Key Financial Metrics
Is SAEYY Expensive or Cheap?
P/E Ratio
SAEYY trades at -31.58 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, SAEYY's PEG of -4.24 indicates potential undervaluation.
Price to Book
The market values Shop Apotheke Europe N.V. at 2.58 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 13.10 times EBITDA. This signals the market has high growth expectations.
How Well Does SAEYY Make Money?
Net Profit Margin
For every $100 in sales, Shop Apotheke Europe N.V. keeps $-1.28 as profit after all expenses.
Operating Margin
Core operations generate -0.97 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-7.70 in profit for every $100 of shareholder equity.
ROA
Shop Apotheke Europe N.V. generates $-3.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Shop Apotheke Europe N.V. generates limited operating cash flow of $28.12M, signaling weaker underlying cash strength.
Free Cash Flow
Shop Apotheke Europe N.V. generates weak or negative free cash flow of $-79.52M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.40 in free cash annually.
FCF Yield
SAEYY converts -6.73% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-31.58
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-4.24
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.58
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.40
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.91
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.55
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.08
vs 25 benchmark
ROA
Return on assets percentage
-0.03
vs 25 benchmark
ROCE
Return on capital employed
-0.03
vs 25 benchmark
How SAEYY Stacks Against Its Sector Peers
| Metric | SAEYY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -31.58 | 29.77 | Better (Cheaper) |
| ROE | -7.70% | 682.00% | Weak |
| Net Margin | -1.28% | -45016.00% (disorted) | Weak |
| Debt/Equity | 0.91 | 0.42 | Weak (High Leverage) |
| Current Ratio | 1.55 | 4.49 | Neutral |
| ROA | -3.00% | -16121.00% (disorted) | Weak |
SAEYY outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Shop Apotheke Europe N.V.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
120.30%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
18.34%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
147.47%
Industry Style: Defensive, Growth, Innovation
High Growth